HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alessandro Piergentili Selected Research

spipethiane

1/2019Investigation of the Role of Chirality in the Interaction with σ Receptors and Effect on Binge Eating Episode of a Potent σ1 Antagonist Analogue of Spipethiane.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alessandro Piergentili Research Topics

Disease

4Neoplasms (Cancer)
03/2022 - 01/2020
3Bulimia (Binge Eating)
10/2021 - 01/2019
3Prostatic Neoplasms (Prostate Cancer)
04/2019 - 12/2005
2Feeding and Eating Disorders (Eating Disorder)
10/2021 - 07/2020
2Neuralgia (Stump Neuralgia)
01/2020 - 09/2017
2Breast Neoplasms (Breast Cancer)
04/2019 - 02/2010
2Parkinson Disease (Parkinson's Disease)
01/2019 - 01/2019
2Pain (Aches)
09/2017 - 11/2009
2Morphine Dependence
07/2012 - 11/2010
1Central Nervous System Diseases (CNS Diseases)
10/2021
1Body Weight (Weight, Body)
10/2021
1Obesity
10/2021
1Bone Resorption
01/2021
1Hyperphagia (Overeating)
10/2020
1Substance-Related Disorders (Drug Abuse)
07/2020
1Schizophrenia (Dementia Praecox)
01/2019
1Dyskinesias (Dyskinesia)
01/2019
1Xerostomia
08/2014
1Depressive Disorder (Melancholia)
09/2013
1Opioid-Related Disorders (Opiate Addiction)
09/2013
1Salter-Harris Fractures
02/2013
1Substance Withdrawal Syndrome (Withdrawal Symptoms)
07/2012

Drug/Important Bio-Agent (IBA)

4LigandsIBA
10/2021 - 09/2017
45-HT1A Serotonin ReceptorIBA
04/2019 - 07/2012
31,4-dioxane (dioxane)IBA
04/2019 - 01/2019
3Morphine (MS Contin)FDA LinkGeneric
11/2010 - 11/2009
2Cisplatin (Platino)FDA LinkGeneric
03/2022 - 04/2020
2CateninsIBA
01/2021 - 02/2013
2Biological ProductsIBA
10/2020 - 04/2019
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
04/2020 - 04/2019
2N-Methylaspartate (NMDA)IBA
04/2020 - 04/2019
2ImidazolinesIBA
01/2020 - 09/2017
1Dopamine D3 ReceptorsIBA
10/2021
1Peptide Hormones (Polypeptide Hormones)IBA
10/2021
1AcyltransferasesIBA
10/2021
1Hormones (Hormone)IBA
10/2021
1Biomarkers (Surrogate Marker)IBA
10/2021
1GhrelinIBA
10/2021
1EnzymesIBA
10/2021
1Glucose (Dextrose)FDA LinkGeneric
10/2021
1Dopamine D4 Receptors (Dopamine D4 Receptor)IBA
07/2020
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2020
1Antineoplastic Agents (Antineoplastics)IBA
04/2019
1Levodopa (L Dopa)FDA LinkGeneric
01/2019
1spipethianeIBA
01/2019
1Pharmaceutical PreparationsIBA
01/2019
1Yohimbine (Yocon)IBA
09/2017
1Gabapentin (Neurontin)FDA LinkGeneric
09/2017
1N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA
09/2017
1Adrenergic Receptors (Adrenergic Receptor)IBA
09/2017
1Ion Channels (Ion Channel)IBA
12/2014
1CalciumIBA
12/2014
1cevimeline (Evoxac)FDA Link
08/2014
1Opiate AlkaloidsIBA
09/2013
1Naloxone (Narcan)FDA LinkGeneric
07/2012
1Antidepressive Agents (Antidepressants)IBA
07/2012
12- (1- (2- allylphenoxy)ethyl)- 4,5- dihydro- 1H- imidazoleIBA
07/2012
1Cytostatic AgentsIBA
02/2010
1Adrenergic Agents (Adrenergic Drugs)IBA
11/2009
1(2- (2- (4- chlorobenzyloxy)phenoxy)ethyl)- (2- (2,6- dimethoxyphenoxy)ethyl)amineIBA
12/2005
1AminesIBA
12/2005
1lissamine rhodamine B (sulforhodamine B)IBA
12/2005

Therapy/Procedure

3Analgesia
11/2010 - 11/2009
2Therapeutics
01/2020 - 01/2019
1Drug Therapy (Chemotherapy)
01/2021
1Oral Administration
01/2020